Novavax Plays Down EU COVID Vaccine Contract Delay

Manufacturing Issues Not To Blame

 
• By Andrew McConaghie
  
Brussels Flags Mask
Novavax is still engaged in negotiations with the European Commission - who will want to avoid further manufacturing delays as seen with AstraZeneca.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip